Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01339572 · ClinicalTrials.gov registry record · Phase 2
Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation
A Phase 2 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 72
- Enrollment target
NCT01339572 is a Phase 2 study that has completed, run by University of Florida. The registered enrollment target is 72 participants.
The verdict
NCT01339572, a Phase 2 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 72 participants
- Enrollment target
Study Summary
This protocol will investigate the effectiveness of plerixafor in the up-front setting in avoiding a second round of mobilization and whether this translates into a clinical and economic benefit.
Interventions
- DRUG Plerixafor
- DRUG Filgrastim
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2011-04 |
| Est. Completion | 2015-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01339572
The ClinicalTrials.gov registry entry for NCT01339572 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Plerixafor is the first listed.
NCT01339572 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01339572 about?
NCT01339572 is a clinical study titled "Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation". This protocol will investigate the effectiveness of plerixafor in the up-front setting in avoiding a second round of mobilization and whether this translates into a clinical and economic benefit.
What is the current status of trial NCT01339572?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 72 participants. The study started on 2011-04. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01339572?
The interventions under investigation include: Plerixafor (DRUG), Filgrastim (DRUG).
Who is sponsoring clinical trial NCT01339572?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.